Symposium Presenters

Caroline Bregman, LICSW, Social Worker, Down Syndrome Program, Massachusetts General Hospital

Peter Bulova, MD, Professor of Medicine, Division of General Internal Medicine, University of Pittsburgh Medical Center

George Capone, MD, Director, Kennedy Krieger Institute's Down Syndrome Clinic and Research Center

Brian Chicoine, MD, Medical Director, Advocate Medical Group Adult Down Syndrome Center; Faculty, Lutheran General Hospital Family Medicine Residency

Jessica Ezzell Hunter, PhD, Director, Genomics, Ethics, and Translational Research Program, RTI International

Hannah Graham, MD, Family Medicine Physician, Advocate Medical Group Adult Down Syndrome Center, Oak Brook, Illinois

Jennifer Harris, MSE, Education Specialist, Anna and John J. Sie Center for Down Syndrome at Children's Hospital Colorado

Jordan Jones, DO, MS, Associate Professor of Pediatrics, Division of Rheumatology, Children's Mercy Hospital

Amanda Laezza, RD, LDN, Dietician, Down Syndrome Program, Massachusetts General Hospital

Andrew McCormick, MD, Director, Healthy Transitions Program, Down Syndrome Center of Western Pennsylvania; Associate Professor of Pediatrics, University of Pittsburgh School of Medicine

Allison Meyer, PhD, Assistant Professor, Department of Pediatrics, University of Colorado School of Medicine; Director of Psychology for the Sie Center for Down Syndrome at Children's Hospital Colorado

Helen Milligan, PT, DPT, PCS, ABPTS Certified Pediatric Clinical Specialist; Assistant Professor, Jefferson College of Rehabilitation Sciences

Dominica Nichols, RD, LDN, PhD, Clinical Nutritionist, Massachusetts General Down Syndrome Program

Nicolas Oreskovic, MD, MPH, Medical Director of Integrated Care Management Program, Massachusetts General Hospital

Lina Patel, PsyD, Program Director for the Down Syndrome Behavioral Health Collaborative at Children's Hospital Colorado; Associate Professor, Department of Psychiatry, University of Colorado School of Medicine

Mary Pipan, MD, Developmental-Behavioral Pediatrician; Director of Trisomy 21 Program, Children's Hospital of Philadelphia

Stephanie Santoro, MD, Clinical Geneticist; Director of Quality Improvement Research, Down Syndrome Program, Massachusetts General Hospital

Bryanna Schwartz, MD, MPH, Pediatric Cardiologist, Children's National Hospital, Washington, DC

Brian Skotko, MD, MPP, Professor of Pediatrics, Harvard Medical School, Emma Campbell Endowed Chair on Down Syndrome, Massachusetts General Hospital

Noemi Spinazzi, MD, Medical Director, Down Syndrome Clinic at UCSF Benioff Children's Hospital Oakland; Associate Clinical Professor, UCSF School of Medicine

Maria Stanley, MD, FAAP, Annual Symposium Committee Co-Chair; Clinical Professor of Pediatrics, University of Wisconsin School of Medicine and Public Health; Medical Director, Waisman Center; Director, Down Syndrome Clinic

Mary Stephens, MD, MPH, FAAFP, FAADM, Medical Director, Jefferson Continuing Care Program (JCCP), Professor, Family and Community Medicine

Kelly Sullivan, PhD, Associate Professor of Pediatrics, Section of Developmental Biology; Boettcher Investigator; Director, Linda Crnic Institute for Down Syndrome Experimental Models Program; Co-Director, Human Medical Genetics and Genomics Graduate Program, University of Colorado Anschutz Medical Campus

Kishore Vellody, MD, Professor of Pediatrics, University of Pittsburgh School of Medicine, Children's Hospital of Pittsburgh, The Paul C. Gaffney Division of Pediatric Hospital Medicine; Adam Piatrandrea Endowed Medical Director, Down Syndrome Center of Western PA

Charlotte Woodward, BA, Education Program Associate for the National Down Syndrome Society (NDSS)

Symposium Planning Committee

Sari Bar, DO, Associate Professor of Pediatrics, UT Southwestern; Medical Director, Developmental-Behavioral Pediatrics Clinic at Children’s Medical Center Dallas

Nicole Baumer, MD, MEd, Director, Sie Center for Down Syndrome; Associate Professor of Pediatrics, University of Colorado-Anschutz Medical Campus

Gabriela Eguiarte Diaz, MD, Pediatrician, Angeles Pedregal Hospital, Mexico

Katie Frank, PhD, OTR/L, Annual Symposium Committee Co-Chair; Occupational Therapist III, Advocate Medical Group Adult Down Syndrome Center

Amy Lyle, MSSW, Clinic Coordinator, Waisman Down Syndrome Clinic, University of Wisconsin-Madison

Andrew McCormick, MD, Director, Healthy Transitions Program, Down Syndrome Center of Western Pennsylvania; Associate Professor of Pediatrics, University of Pittsburgh School of Medicine

Meghan O'Neill, MD, FAAP, National Institutes of Health (NIH); Attending Physician, Developmental and Behavioral Pediatrics; Attending Physician, Neurology, Lurie Children’s Hospital; Assistant Professor of Pediatrics (Developmental Behavioral Pediatrics, Child Neurology), Northwestern University Feinberg School of Medicine

Lina Patel, PsyD, Program Director for the Down Syndrome Behavioral Health Collaborative at Children's Hospital Colorado; Associate Professor, Department of Psychiatry, University of Colorado School of Medicine

Emilie Perkins, Director of Client and Conference Services, Raybourn Group International

Moya Peterson, PhD, APRN, FNP-BC, Adults with Down Syndrome Specialty Clinic, Department of Family Medicine and Community Health, University of Kansas Medical Center

Dannah Raz, MD, Interim Division Chief, Developmental Pediatrics, Barrow Neurological Institute of Phoenix Children's

Noemi Spinazzi, MD, Medical Director, Down Syndrome Clinic at UCSF Benioff Children's Hospital Oakland; Associate Clinical Professor, UCSF School of Medicine

Maria Stanley, MD, FAAP, Annual Symposium Committee Co-Chair; Clinical Professor of Pediatrics, University of Wisconsin School of Medicine and Public Health; Medical Director, Waisman Center; Director, Down Syndrome Clinic

Policy on Faculty and Sponsor Disclosure

It is the policy of the University of Wisconsin–Madison Interprofessional Continuing Education Partnership (ICEP) to identify, mitigate and disclose all relevant financial relationships with ineligible companies* held by the speakers/presenters, authors, planners, and other persons who may influence the content of this accredited continuing education (CE).  In addition, speakers, presenters and authors must disclose any planned discussion of unlabeled/unapproved uses of drugs or devices during their presentation.

*Ineligible companies are those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by, or on, patients. The ACCME does not consider providers of clinical services directly to patients to be ineligible companies.